Human Tissue Microarray (SO100-01A)

Sarcoma Tumor Tissue Microarray - 1 core per case - 50 Liposarcoma cases - 50 Rahbdomyosarcoma cases - 1 Matched Normal Seletal tissue case (NAT)

$300.00

Overview

More Information
Species	Human
Section Thickness	5 µm
Fixative	Formalin
Total Cases	100
Total Cores	101
Core Diameter	1.0 mm
Storage	Short term RT
Usage	For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Specification

USBIOLAB

No.	Map ID	Age	Sex	Organ	Pathology Diagnosis	Grade	TNM	Stage	Type	Block ID
1	A1	76	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP1
2	A2	52	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP2
3	A3	29	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP4
4	A4	41	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP6
5	A5	48	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP7
6	A6	30	M	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP8
7	A7	46	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP9
8	A8	47	F	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP10
9	A9	67	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	IIB	Malignant Primary	LIP12
10	A10	60	M	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP14
11	B1	71	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP15
12	B2	45	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP17
13	B3	49	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP18
14	B4	39	M	Soft Tissue	Liposarcoma	G3	T2bN0M0	IIB	Malignant Primary	LIP19
15	B5	36	F	Soft Tissue	Liposarcoma	G2	T2bN0M0	IIB	Malignant Primary	LIP20
16	B6	74	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LIP21
17	B7	41	F	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP22
18	B8	70	F	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LIP23
19	B9	56	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LIP24
20	B10	55	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP25
21	C1	33	M	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP27
22	C2	56	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP28
23	C3	54	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP29
24	C4	59	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	IIB	Malignant Primary	LIP30
25	C5	72	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	IIB	Malignant Primary	LIP31
26	C6	56	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP33
27	C7	40	F	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LIP34
28	C8	36	F	Soft Tissue	Liposarcoma	G2	T2bN0M0	IIB	Malignant Primary	LIP35
29	C9	33	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LIP36
30	C10	75	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP38
31	D1	58	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP39
32	D2	28	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP40
33	D3	32	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LIP41
34	D4	24	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP42
35	D5	64	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP45
36	D6	60	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP46
37	D7	67	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	IIB	Malignant Primary	LIP49
38	D8	70	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP51
39	D9	43	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP55
40	D10	57	F	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LIP58
41	E1	71	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LIP59
42	E2	65	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	IIB	Malignant Primary	LIP61
43	E3	57	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	III	Malignant Primary	LIP64
44	E4	43	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LIP70
45	E5	32	M	Soft Tissue	Liposarcoma	G2	T2bN0M0	III	Malignant Primary	LIP71
46	E6	37	F	Soft Tissue	Liposarcoma	G3	T2bN0M0	III	Malignant Primary	LIP72
47	E7	39	F	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LP-107
48	E8	54	M	Soft Tissue	Liposarcoma	G3	T2aN0M0	IIB	Malignant Primary	LP-113
49	E9	59	M	Soft Tissue	Liposarcoma	G2	T2aN0M0	III	Malignant Primary	LP-117
50	E10	55	M	Soft Tissue	Liposarcoma	G3	T2bN0M0	IIB	Malignant Primary	LP-118
51	F1	18	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD1
52	F2	54	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD7
53	F3	40	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD8
54	F4	44	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD16
55	F5	56	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD17
56	F6	67	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD14
57	F7	66	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD22
58	F8	22	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD25
59	F9	41	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD27
60	F10	57	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T1bN0M0	IIA	Malignant Primary	RD34
61	G1	54	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD38
62	G2	61	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD40
63	G3	36	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD41
64	G4	70	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD44
65	G5	55	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD46
66	G6	67	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T1bN0M0	IIA	Malignant Primary	RD47
67	G7	35	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD48
68	G8	55	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD49
69	G9	67	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD50
70	G10	56	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD52
71	H1	34	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD54
72	H2	64	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD58
73	H3	19	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD59
74	H4	32	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD61
75	H5	39	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD64
76	H6	50	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD65
77	H7	56	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD67
78	H8	37	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD68
79	H9	70	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RD69
80	H10	56	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RD70
81	I1	27	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-183
82	I2	57	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-185
83	I3	58	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-186
84	I4	67	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-187
85	I5	38	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-190
86	I6	37	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-191
87	I7	69	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-192
88	I8	45	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-195
89	I9	57	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-197
90	I10	45	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-198
91	J1	70	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-200
92	J2	70	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-204
93	J3	56	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-205
94	J4	67	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-207
95	J5	55	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T1bN0M0	IIA	Malignant Primary	RB-209
96	J6	30	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-210
97	J7	46	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-215
98	J8	51	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2aN0M0	III	Malignant Primary	RB-217
99	J9	31	F	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-218
100	J10	54	M	Skeleal Muscle	Rhabdomyosarcoma	G3	T2bN0M0	III	Malignant Primary	RB-220
101	J11	46	M	Skeleal Muscle	Normal Tissue (Matched NAT J7)	-	-	-	NAT	RB-215

Downloads

Download Data Sheet File:SO100-01A

Skip to the end of the images gallery

Skip to the beginning of the images gallery